Swab and viral transport medium sales will expand through 2036, with virus swabs at 59.0% within the product type segment and varicella-zoster virus at 32.6% of the application category in 2026. The market is estimated at USD 1,999.4 million in 2026 and is forecast to record a 2.9% CAGR between 2026 and 2036.